抗髓鞘少突胶质细胞糖蛋白IgG抗体相关疾病临床及影像特征

doi:10.6040/j.issn.1671-7554.0.2021.1149

摘要/Abstract

摘要： 目的探讨抗髓鞘少突胶质细胞糖蛋白IgG抗体相关疾病(MOGAD)的临床及影像学特征。方法选取2018年9月至2021年6月在山东第一医科大学附属省立医院确诊的MOGAD的临床及影像学资料,进行回顾性总结分析。结果 19例MOGAD患者中男9例,女10例,中位年龄10岁。患者临床表型为视神经脊髓炎谱系疾病者7例,急性播散性脑脊髓炎者6例,脑炎者4例［其中1例合并抗N-甲基-D-天冬氨酸受体(NMDAR)脑炎］,脊髓炎者1例,脑干脑炎者1例。17例(17/19)患者颅脑磁共振成像(MRI)检查发现异常信号,病变可累及脑组织任何部位,表现为多灶性、边界不清的点片状T₂WI高信号。4例(4/13)患者脊柱MRI检查发现脊髓异常信号。4例(4/9)患者眼眶MRI检查发现异常信号,表现为视神经T₂WI高信号;2例病变累及视交叉、视束。19例患者血清 MOG-IgG 抗体均为阳性,其中1例合并NMDAR抗体阳性,1例合并甲状腺过氧化物酶抗体阳性。结论 MOGAD多见于儿童青少年,临床表型多样且与年龄相关。病变可累及视神经、脊髓、颅脑等多个部位,影像学表现多样。

关键词: 髓鞘少突胶质细胞糖蛋白抗体, 视神经脊髓炎谱系疾病, 多发性硬化, 磁共振成像

Abstract: Objective To investigate the clinical and imaging features of anti-myelin oligodendrocyte glycoprotein-IgG antibody associated disorders(MOGAD). Methods The clinical and imaging data of 19 MOGAD patients confirmed in Shandong Provincial Hospital Affiliated to Shandong First Medical University during Sep. 2018 and Jun. 2021 were retrospectively analyzed. Results The patients included 9 males and 10 females, with a median age of 10 years. Seven cases manifested asaquaporin4(AQP4)negative neuromyelitis optica spectrum disorder(NMOSD); 6 cases presented with acute disseminated encephalomyelitis(ADEM); 4 cases presented with encephalitis, 1 of which complicated with anti-N-methyld-aspartate receptor(NMDAR)encephalitis; 1 case presented with transverse myelitis; 1 case presented with brainstem encephalitis. Abnormal signals were detected with brain MRI in 17 cases(17/19), and the lesions could be involved in any part of the brain, presenting multifocal ill-defined T₂WI hyperintensity. Spinal MRI found abnormal signals in 4 cases(4/13). Orbital MRI detected abnormal signals in 4 cases(4/9), presenting T₂WI hyperintensity in optic nerves, 2 of which(2/4)showed optic crossover and optic tract. The serum MOG-IgG antibody of all patients was positive; 1 case was NMDAR antibody positive; 1 case was thyroidperoxidase antibody positive. Conclusion The MOGAD clinical phenotype is associated with age, more common in children and adolescents, and prone to relapse. Lesions can involve the optic nerves, spinal cord, intracranial and other parts. The imaging performance is varied.

Key words: Myelin oligodendrocyte glycoprotein antibody, Neuromyelitis optica spectrum disorder, Multiple sclerosis, Magnetic resonance imaging

中图分类号:

R445.2

冯宝民,王舟,徐晗,李佳存,于乔文,修建军. 抗髓鞘少突胶质细胞糖蛋白IgG抗体相关疾病临床及影像特征[J]. 山东大学学报 (医学版), 2022, 60(3): 45-50.

FENG Baomin, WANG Zhou, XU Han, LI Jiacun, YU Qiaowen, XIU Jianjun. Clinical and imaging features of 19 cases of anti-myelin oligodendrocyte glycoprotein-IgG antibody associated disorders[J]. Journal of Shandong University (Health Sciences), 2022, 60(3): 45-50.

参考文献

[1] Wynford-Thomas R, Jacob A, Tomassini V. Neurological update: MOG antibody disease [J]. J Neurol, 2019, 266(5): 1280-1286.
[2] 中国免疫学会神经免疫分会. 抗髓鞘少突胶质细胞糖蛋白免疫球蛋白G抗体相关疾病诊断和治疗中国专家共识[J]. 中国神经免疫学和神经病学杂志, 2020, 27(2): 86-95.
[3] Linington C, Morgan BP, Scolding NJ, et al. The role of complement in the pathogenesis of experimental allergic encephalomyelitis [J]. Brain, 1989, 112(Pt 4): 895-911.
[4] Cobo-Calvo A, Ruiz A, Maillart E, et al. Clinical spectrum and prognostic value of CNS MOG autoimmunity in adults: The MOGADOR study [J]. Neurology, 2018, 90(21): e1858-e1869.
[5] Akaishi T, Nakashima I, Takeshita T, et al. Different etiologies and prognoses of optic neuritis in demyelinating diseases [J]. J Neuroimmunol, 2016, 299: 152-157. doi: 10.1016/j.jneuroim.2016.09.007.
[6] Jarius S, Paul F, Aktas O, et al. MOG encephalomyelitis: international recommendations on diagnosis and antibody testing [J]. J Neuroinflammation, 2018, 15(1): 134. doi:10.1186/s12974-018-1144-2.
[7] Dale RC, Tantsis EM, Merheb V, et al. Antibodies to MOG have a demyelination phenotype and affect oligodendrocyte cytoskeleton [J]. Neurol Neuroimmunol Neuroinflamm, 2014, 1(1): e12. doi:10.1212/NXI.0000000000000012.
[8] Reindl M, Waters P. Myelin oligodendrocyte glycoprotein antibodies in neurological disease [J]. Nat Rev Neurol, 2019, 15(2): 89-102.
[9] Jurynczyk M, Messina S, Woodhall MR, et al. Clinical presentation and prognosis in MOG-antibody disease: a UK study [J]. Brain, 2017, 140(12): 3128-3138.
[10] Cole J, Evans E, Mwangi M, et al. Acute disseminated encephalomyelitis in children: an updated review based on current diagnostic criteria [J]. Pediatr Neurol, 2019, 100: 26-34. doi: 10.1016/j.pediatrneurol.2019.06.017.
[11] 李波, 陈中婕, 奚玲如,等. 成人MOG抗体相关性脑脊髓炎患者15例临床特点分析[J]. 新医学, 2021, 52(1): 6. LI Bo, CHEN Zhongjie, XI Lingru, et al. Clinical characteristics of 15 adult cases of MOG-IgG-associated encephalomyelitis [J]. Journal of New Medicine, 2021, 52(1): 6.
[12] 李波, 王展航, 潘梦秋, 等. 儿童MOG抗体阳性的中枢神经系统脱髓鞘病变12例临床特点分析[J]. 中国神经免疫学和神经病学杂志, 2020, 27(1): 40-45. LI Bo, WANG Zhanhang, PAN Mengqiu, et al. Clinical characteristics of 12 cases of children with MOG-IgG associated central nervous system demyelination [J]. Chin J Neuroimmunol&Neurol, 2020, 27(1): 40-45.
[13] Sepúlveda M, Armangue T, Martinez-Hernandez E, et al. Clinical spectrum associated with MOG autoimmunity in adults: significance of sharing rodent MOG epitopes [J]. J Neurol, 2016, 263(7): 1349-1360.
[14] Kim HJ, Paul F, Lana-Peixoto MA, et al. MRI characteristics of neuromyelitis optica spectrum disorder: an international update [J]. Neurology, 2015, 84(11): 1165-1173.
[15] Jarius S, Ruprecht K, Kleiter I, et al. MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 1: Frequency, syndrome specificity, influence of disease activity, long-term course, association with AQP4-IgG, and origin [J]. J Neuroinflammation, 2016, 13(1): 279. doi:10.1186/s12974-016-0717-1.
[16] Dubey D, Pittock SJ, Krecke KN, et al. Clinical, radiologic, and prognostic features of myelitis associated with myelin oligodendrocyte glycoprotein autoantibody [J]. JAMA Neurol, 2019, 76(3):301-309.
[17] Sato DK, Callegaro D, Lana-Peixoto MA, et al. Distinction between MOG antibody-positive and AQP4 antibody-positive NMO spectrum disorders [J]. Neurology, 2014, 82(6):474-481.
[18] Geraldes R, Ciccarelli O, Barkhof F, et al. The current role of MRI in differentiating multiple sclerosis from its imaging mimics [J]. Nat Rev Neurol, 2018, 14(4): 199-213.
[19] Cobo-Calvo A, Vukusic S, Marignier R. Clinical spectrum of central nervous system myelin oligodendrocyte glycoprotein autoimmunity in adults [J]. Curr Opin Neurol, 2019, 32(3): 459-466.
[20] Carra-Dalliere C, Menjot de Champfleur N, Ayrignac X, et al. Optic chiasm and oculomotor nerves involvement in active multiple sclerosis [J]. J Neuroradiol, 2020, 47(1): 62-64.

相关文章 15

[1]	金晨曦,沈薇,李娜,孙建锋,杨驰,郭泾. ADDWoR关节镜下盘复位术盘-髁运动的定量分析[J]. 山东大学学报 (医学版), 2025, 63(7): 54-61.
[2]	刘晶晶,庞婧,赵晓丹,林昕,付敏,陈静静. 基于乳腺X线摄影及DCE-MRI机器学习模型预测乳腺癌新辅助治疗后病理完全缓解:双中心研究[J]. 山东大学学报 (医学版), 2025, 63(1): 60-72.
[3]	刘海霞,皇甫莎莎,桑晓玉,崔东清,毕建忠,王萍. 间充质干细胞对实验性自身免疫性脑脊髓炎小鼠铁死亡的影响[J]. 山东大学学报 (医学版), 2024, 62(6): 1-8.
[4]	刘小文,曹永泉,侯明源,于德新. EOB-MRI多定量参数对肝胆期乏血供低信号结节进展风险的评估价值[J]. 山东大学学报 (医学版), 2024, 62(4): 31-39.
[5]	吴思雨,沈业隆,王锡明. 影像组学预测原发性中枢神经系统淋巴瘤的Ki-67标记指数[J]. 山东大学学报 (医学版), 2024, 62(11): 67-72.
[6]	靳新娟,左立平,邓展昊,李安宁,于德新. MRI影像组学对135例肝癌耐药蛋白PFKFB3的预测价值[J]. 山东大学学报 (医学版), 2023, 61(6): 79-86.
[7]	王磊,张帅,刘钢,由胜男,王植,朱珊,陈超,马信龙,杨强. MRI诊断140例腰椎智能网络自动检测分型MCs方法的比较[J]. 山东大学学报 (医学版), 2023, 61(3): 71-79.
[8]	杨咏青,赵鹏,汪玉,马文静,田迷迷,程亚旎,祖璐,林祥涛. 细胞外容积分数对62例不同病理类型肺癌的诊断价值[J]. 山东大学学报 (医学版), 2023, 61(2): 88-94.
[9]	靳新娟,蔡大幸,范金蕾,邓展昊,李楠,于德新,李安宁. 显微镜高分辨率MRI鉴别皮肤良、恶性局灶隆起性结节[J]. 山东大学学报 (医学版), 2023, 61(12): 51-61.
[10]	侯少瑾,王云凤,曹丽丽,刘学伍,赵秀鹤,王胜军. 视神经脊髓炎谱系疾病53例与多发性硬化11例的脑脊液检测比较[J]. 山东大学学报 (医学版), 2023, 61(1): 32-37.
[11]	赵恩举,赵硕,郭云亮,王锡明. 282例颈动脉钙化与脑小血管病MRI总负荷评分的关联性[J]. 山东大学学报 (医学版), 2023, 61(1): 38-44.
[12]	陶国伟,王芳,董向毅,徐亚瑄,赵琳丽,胡蓓蓓. 子宫腺肌病的超声与MRI诊断及进展[J]. 山东大学学报 (医学版), 2022, 60(7): 56-65.
[13]	李鸿皓,于晶,陈亚丽,郭守刚. 20例NMOSD患者CD4⁺CD25⁺FoxP3⁺调节性T细胞数量和FoxP3 mRNA的表达水平[J]. 山东大学学报 (医学版), 2022, 60(4): 50-54.
[14]	左立平,蒋丰洋,周斌彬,范金蕾,梁永锋,邓展昊,于德新. 术前MRI在预测169例肝细胞肝癌微血管侵犯及早期复发的价值[J]. 山东大学学报 (医学版), 2022, 60(3): 89-95.
[15]	刘学业,李齐明,唐弘毅,徐秋平,陈文倩,郭泾. 年轻成人颞下颌关节髁突体积、表面积与关节盘矢向位置的关系[J]. 山东大学学报 (医学版), 2021, 59(6): 117-121.

多维度评价

Viewed

Full text

Abstract

Cited

Shared

Discussed